© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
An antibody treatment plus an immune-stimulating agent delayed viral rebound in primates infected with HIV-like virus.
A new analysis finds that Gilead Sciences’ updated version of its key antiretroviral tenofovir may not actually offer any safety benefits.
Aside from taking antiretrovirals, quitting smoking is the number one way people with HIV can lower their risk of illness and death.
Mayer joins Journal of the International AIDS Society co–editors-in-chief Susan Kippax and Papa Salif Sow.
Long-living, stem-cell-like immune cells appear to be a bedrock of the viral reservoir that prevents antiretroviral treatment from clearing th...
Two HIV-positive men who each displayed no signs of the virus after stem cell transplants to treat their lymphoma have both experienced a vira...
Super sensitive tests have not been able to detect any virus in two HIV-positive men after each received reduced-intensity chemotherapy follow...
Close adherence to a pre-exposure prophylaxis (PrEP) regimen spells success in preventing HIV transmission within heterosexual couples in...
There is no sign of virus in two HIV-positive people with lymphoma who received stem cell transplants and then later stopped taking their anti...
Studies have not yet produced a solid argument for such early treatment.
The World Bank has selected Jim Yong Kim, MD, PhD, as its president, The New York Times reports.
POZ helps you save 100 bucks or more each month.
Recent news about a possible cure for HIV in a stem cell transplant patient could jump-start the related field of gene therapy. Stem cell expe...
Emerging data suggest that starting antiretroviral therapy earlier than is currently recommended provides even greater protection against illn...
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
